Bank Of New York Mellon Corp Denali Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$21.91 - $32.67 $44.2 Million - $65.9 Million	2,016,623 New	2,016,623 $46.5 Billion
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $52.7 Million - $68 Million	2,005,920 New	2,005,920 $55.8 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $705,397 - $1.05 Million	27,162 Added 1.45%	1,895,292 $58.2 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $5.41 Million - $9.11 Million	258,913 Added 16.09%	1,868,130 $55 Million
Q1 2022 May 11, 2022	BUY	$29.0 - $47.27 $19.6 Million - $32 Million	676,625 Added 72.55%	1,609,217 $51.8 Million
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $23.7 Million - $30.6 Million	555,873 Added 147.56%	932,592 $41.6 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $1.42 Million - $2.3 Million	29,350 Added 8.45%	376,719 $19 Million
Q2 2021 Aug 11, 2021	BUY	$50.3 - $78.44 $4.33 Million - $6.75 Million	86,005 Added 32.91%	347,369 $27.2 Million
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $9.58 Million - $14.5 Million	-178,006 Reduced 40.51%	261,364 $14.9 Million
Q4 2020 Feb 09, 2021	SELL	$36.89 - $93.56 $10.7 Million - $27 Million	-288,839 Reduced 39.66%	439,370 $36.8 Million
Q3 2020 Nov 12, 2020	BUY	$23.13 - $38.84 $1.9 Million - $3.19 Million	82,247 Added 12.73%	728,209 $26.1 Million
Q2 2020 Aug 12, 2020	BUY	$16.01 - $28.82 $4.84 Million - $8.71 Million	302,215 Added 87.92%	645,962 $15.6 Million
Q1 2020 May 06, 2020	BUY	$14.2 - $27.98 $106,741 - $210,325	7,517 Added 2.24%	343,747 $6.02 Million
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $38,692 - $53,713	-2,687 Reduced 0.79%	336,230 $5.86 Million
Q3 2019 Nov 07, 2019	BUY	$15.32 - $21.92 $1.71 Million - $2.45 Million	111,897 Added 49.29%	338,917 $5.19 Million
Q2 2019 Aug 12, 2019	SELL	$18.5 - $28.14 $21,349 - $32,473	-1,154 Reduced 0.51%	227,020 $4.71 Million
Q1 2019 May 14, 2019	BUY	$17.99 - $24.65 $12,035 - $16,490	669 Added 0.29%	228,174 $5.3 Million
Q4 2018 Feb 11, 2019	BUY	$13.88 - $21.75 $330,468 - $517,845	23,809 Added 11.69%	227,505 $4.7 Million
Q3 2018 Nov 09, 2018	BUY	$12.46 - $21.74 $1.78 Million - $3.1 Million	142,500 Added 232.86%	203,696 $0
Q2 2018 Aug 06, 2018	BUY	$15.25 - $21.02 $135,450 - $186,699	8,882 Added 16.98%	61,196 $933,000
Q1 2018 May 15, 2018	BUY	$15.36 - $24.8 $803,543 - $1.3 Million	52,314 New	52,314 $1.03 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account